BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Lancet 



     
Phone: Fax:


SEARCH JOBS










 Company News
Merck & Co. (MRK) Announces Publication Of Pivotal Data From Phase 3 Clinical Studies Of ZERBAXA (Ceftolozane/Tazobactam) In The Lancet And Clinical Infectious Diseases 4/28/2015 10:35:12 AM
GlaxoSmithKline (GSK)'s Malaria Vaccine Phase III Study Containing Agenus’ QS-21 Published In The Lancet 4/24/2015 7:29:41 AM
Lancet And ChemRar High Tech Center Have Announced a Partnership in the Development and Production of Novel Drugs in Russia 4/16/2015 8:17:00 AM
The Lancet Publishes The First Ever Successful Series of Clinical Heart Transplants From DCD Donors Using The TransMedics, Inc. Organ Care System (OCS) 4/15/2015 2:18:11 PM
Lancet Release: The Results Of The International PROCEED II Heart Trial With The Organ Care System (OCS) Were Published Today In The Prestigious Lancet Journal 4/15/2015 2:06:21 PM
The Lancet Publishes CSL Behring's Kcentra Phase III Data 3/17/2015 7:25:40 AM
Takeda (TKPYY) Announces Publication In The Lancet Of A Post Hoc Analysis Of Data From The EXAMINE Cardiovascular Safety Outcomes Trial 3/10/2015 6:50:24 AM
Teva Pharmaceutical Industries (TEVA) Release: The Lancet Respiratory Medicine And AAAAI Publish Positive Data From Phase 3 Trials Of Teva’s Reslizumab For The Treatment Of Moderate To Severe Asthma In Patients With Elevated Blood Eosinophils 2/24/2015 11:46:40 AM
The Lancet Publishes Largest Pivotal Study In China Comparing IGRA And TST Testing For Latent Tuberculosis Infection 2/11/2015 11:21:37 AM
Most Commonly Prescribed Glaucoma Drug Reduces Risk Of Vision Loss By More Than 50% Over 2 Years: Lancet 12/19/2014 7:39:32 AM
12345678910...